ESC Premium Access

Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial.

Topic: Lipids (Epidemiology and Prevention)

Congress Presentation

About the speaker

Professor Martin Landray

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
7 presentations
0 follower

Access the full session

Meet the Trialists - HPS3/TIMI55-REVEAL

Speakers: Professor M. Landray

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb